Brief: Guardant Health Q4 Adjusted EPS USD -0.62 Vs. IBES Estimate USD -0.74
20/02/2025 21:05
Feb 20 (Reuters) - Guardant Health Q4 adjusted EBITDA USD -78.4 million vs. IBES estimate USD -63.9 million. * Q4 EPS USD -0.9 * Q4 adjusted net income USD -77.3 million vs. IBES estimate USD -94.3 million * outlook FY revenue USD 850-860 million
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte